Yanyan Zhu

Statistics

Publications

Citations

531

H-Index

Active since

2008

Affiliations

Millennium Engineering and Integration (United States)(Current)

Takeda (United States)

21st Century Oncology (United States)

Institute of Cancer Research

Royal Marsden Hospital

Yanyan Zhu is an author at Millennium Engineering and Integration (United States) specializing in oncology, medicine, and non-small cell lung cancer therapy.

ORCID

Publications per year

2008–2023

Publications

Large-Scale Analysis of <i>KIT</i> Aberrations in Chinese Patients with Melanoma

Yan Kong, Lu Si, Yanyan Zhu et al. · Clinical Cancer Research · 2011 · 252 citations

Medicine, Genetics, Oncology +16

The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial

David P. Dearnaley, Daniel R. Saltzstein, John E. Sylvester et al. · European Urology · 2020 · 74 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor–naive ALK + non−small cell lung cancer (ALTA-1L)

M.R. García Campelo, Huamao Mark Lin, Yanyan Zhu et al. · Lung Cancer · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacology +13

Long-term cadmium exposure induces chronic obstructive pulmonary disease-like lung lesions in a mouse model

Wenjing Wang, Kun Peng, Xue Lu et al. · The Science of The Total Environment · 2023 · 33 citations

Veterinary Medicine, Pathobiology, Toxicology +14

Analyzing the prognostic value of DKK1 expression in human cancers based on bioinformatics

Ruqiong Wei, Raquel Alarcón, Zhi-biao Tan et al. · Annals of Translational Medicine · 2020 · 32 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

1–5 of 11